ArticleNature communications2026

Anti-PD-1 plus anti-CTLA-4 blockade overcomes immune exclusion in NSCLC brain metastases by enhancing CD8

Kazutaka Hosoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.